Absci
ABSI
NASDAQ
IPO2021
about ABSI
Absc is a biotechnology company focused on pioneering innovative therapies and advancing treatments in areas such as oncology, inflammation, and central nervous system disorders through cutting-edge computational methods and machine learning approaches.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.05 | $3.20 | $2.90 | $463.14M | 3.14M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.20 | n/a | 1108.70 | -7977.25% | -7594.18% | 0% |